APO Research
Talk to an analyst

APO RESEARCH · REPORT

Hydromorphone

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Hydromorphone Market Outlook and Growth Opportunities 2026

19 December 2025203 pages

Choose your research edition.

Industry ResearchHydromorphone Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Hydromorphone Industry Growth and Trends Forecast to 2032117 pages · $3,450 USDMarket StructureGlobal Hydromorphone Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Hydromorphone Market Outlook and Growth Opportunities 2026203 pages · $4,250 USDMarket Analysis & ForecastGlobal Hydromorphone Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

The global Hydromorphone market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Hydromorphone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Hydromorphone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Hydromorphone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Hydromorphone market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Hydromorphone market include Teva Pharmaceuticals, Johnson & Johnson, Novartis, Mylan, Pfizer, Fresenius, Watson Laboratories, Stada Arzneimittel and Purdue Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Hydromorphone market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Hydromorphone and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Hydromorphone sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Hydromorphone market size, projected growth trends, production technologies, key applications, and end-use industries.

Hydromorphone Segment by Company

Teva Pharmaceuticals

Johnson & Johnson

Novartis

Mylan

Pfizer

Fresenius

Watson Laboratories

Stada Arzneimittel

Purdue Pharma

Mundipharma

Mallinckrodt

Lannett

KV Pharmaceutical

Barr Pharmaceuticals

Apotex

Akorn

Hydromorphone Segment by Type

Oral

Injection

Hydromorphone Segment by Application

Hospital

Drug Store

Hydromorphone Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Hydromorphone status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Hydromorphone market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Hydromorphone significant trends, drivers, influence factors in global and regions.

6. To analyze Hydromorphone competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hydromorphone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hydromorphone and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hydromorphone.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Hydromorphone market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Hydromorphone industry.

Chapter 3: Detailed analysis of Hydromorphone manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Hydromorphone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Hydromorphone in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Hydromorphone Industry Trends Table 2. Hydromorphone Industry Drivers Table 3. Hydromorphone Industry Opportunities and Challenges Table 4. Hydromorphone Industry Restraints Table 5. Global Hydromorphone Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Hydromorphone Revenue Share by Company (2021-2026) Table 7. Global Hydromorphone Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Hydromorphone Sales Volume Share by Company (2021-2026) Table 9. Global Hydromorphone Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Hydromorphone Company Ranking, (2024-2026) & (USD Million) Table 11. Global Hydromorphone Key Company Manufacturing Base & Headquarters Table 12. Global Hydromorphone Company, Product Type & Application Table 13. Global Hydromorphone Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Hydromorphone by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Oral Table 18. Significant Companies of Injection Table 19. Global Hydromorphone Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Hydromorphone Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Hydromorphone Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Hydromorphone Sales Volume Share by Type (2021-2026) Table 23. Global Hydromorphone Sales Volume Share by Type (2027-2032) Table 24. Global Hydromorphone Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Hydromorphone Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Hydromorphone Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Hydromorphone Sales Value Share by Type (2021-2026) Table 28. Global Hydromorphone Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital Table 30. Significant Companies of Drug Store Table 31. Global Hydromorphone Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Hydromorphone Sales Volume by Application (2021-2026) & (K Units) Table 33. Global Hydromorphone Sales Volume by Application (2027-2032) & (K Units) Table 34. Global Hydromorphone Sales Volume Share by Application (2021-2026) Table 35. Global Hydromorphone Sales Volume Share by Application (2027-2032) Table 36. Global Hydromorphone Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Hydromorphone Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Hydromorphone Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Hydromorphone Sales Value Share by Application (2021-2026) Table 40. Global Hydromorphone Sales Value Share by Application (2027-2032) Table 41. Global Hydromorphone Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Hydromorphone Sales by Region (2021-2026) & (K Units) Table 43. Global Hydromorphone Sales Market Share by Region (2021-2026) Table 44. Global Hydromorphone Sales by Region (2027-2032) & (K Units) Table 45. Global Hydromorphone Sales Market Share by Region (2027-2032) Table 46. Global Hydromorphone Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Hydromorphone Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Hydromorphone Sales Value Share by Region (2021-2026) Table 49. Global Hydromorphone Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Hydromorphone Sales Value Share by Region (2027-2032) Table 51. Global Hydromorphone Market Average Price (US$/Unit) by Region (2021-2026) Table 52. Global Hydromorphone Market Average Price (US$/Unit) by Region (2027-2032) Table 53. Global Hydromorphone Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Global Hydromorphone Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Hydromorphone Sales by Country (2021-2026) & (K Units) Table 56. Global Hydromorphone Sales Market Share by Country (2021-2026) Table 57. Global Hydromorphone Sales by Country (2027-2032) & (K Units) Table 58. Global Hydromorphone Sales Market Share by Country (2027-2032) Table 59. Global Hydromorphone Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Hydromorphone Sales Value Market Share by Country (2021-2026) Table 61. Global Hydromorphone Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Hydromorphone Sales Value Market Share by Country (2027-2032) Table 63. Teva Pharmaceuticals Company Information Table 64. Teva Pharmaceuticals Business Overview Table 65. Teva Pharmaceuticals Hydromorphone Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Teva Pharmaceuticals Hydromorphone Product Portfolio Table 67. Teva Pharmaceuticals Recent Development Table 68. Johnson & Johnson Company Information Table 69. Johnson & Johnson Business Overview Table 70. Johnson & Johnson Hydromorphone Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Johnson & Johnson Hydromorphone Product Portfolio Table 72. Johnson & Johnson Recent Development Table 73. Novartis Company Information Table 74. Novartis Business Overview Table 75. Novartis Hydromorphone Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Novartis Hydromorphone Product Portfolio Table 77. Novartis Recent Development Table 78. Mylan Company Information Table 79. Mylan Business Overview Table 80. Mylan Hydromorphone Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Mylan Hydromorphone Product Portfolio Table 82. Mylan Recent Development Table 83. Pfizer Company Information Table 84. Pfizer Business Overview Table 85. Pfizer Hydromorphone Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Pfizer Hydromorphone Product Portfolio Table 87. Pfizer Recent Development Table 88. Fresenius Company Information Table 89. Fresenius Business Overview Table 90. Fresenius Hydromorphone Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Fresenius Hydromorphone Product Portfolio Table 92. Fresenius Recent Development Table 93. Watson Laboratories Company Information Table 94. Watson Laboratories Business Overview Table 95. Watson Laboratories Hydromorphone Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Watson Laboratories Hydromorphone Product Portfolio Table 97. Watson Laboratories Recent Development Table 98. Stada Arzneimittel Company Information Table 99. Stada Arzneimittel Business Overview Table 100. Stada Arzneimittel Hydromorphone Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Stada Arzneimittel Hydromorphone Product Portfolio Table 102. Stada Arzneimittel Recent Development Table 103. Purdue Pharma Company Information Table 104. Purdue Pharma Business Overview Table 105. Purdue Pharma Hydromorphone Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Purdue Pharma Hydromorphone Product Portfolio Table 107. Purdue Pharma Recent Development Table 108. Mundipharma Company Information Table 109. Mundipharma Business Overview Table 110. Mundipharma Hydromorphone Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Mundipharma Hydromorphone Product Portfolio Table 112. Mundipharma Recent Development Table 113. Mallinckrodt Company Information Table 114. Mallinckrodt Business Overview Table 115. Mallinckrodt Hydromorphone Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Mallinckrodt Hydromorphone Product Portfolio Table 117. Mallinckrodt Recent Development Table 118. Lannett Company Information Table 119. Lannett Business Overview Table 120. Lannett Hydromorphone Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Lannett Hydromorphone Product Portfolio Table 122. Lannett Recent Development Table 123. KV Pharmaceutical Company Information Table 124. KV Pharmaceutical Business Overview Table 125. KV Pharmaceutical Hydromorphone Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. KV Pharmaceutical Hydromorphone Product Portfolio Table 127. KV Pharmaceutical Recent Development Table 128. Barr Pharmaceuticals Company Information Table 129. Barr Pharmaceuticals Business Overview Table 130. Barr Pharmaceuticals Hydromorphone Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 131. Barr Pharmaceuticals Hydromorphone Product Portfolio Table 132. Barr Pharmaceuticals Recent Development Table 133. Apotex Company Information Table 134. Apotex Business Overview Table 135. Apotex Hydromorphone Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 136. Apotex Hydromorphone Product Portfolio Table 137. Apotex Recent Development Table 138. Akorn Company Information Table 139. Akorn Business Overview Table 140. Akorn Hydromorphone Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 141. Akorn Hydromorphone Product Portfolio Table 142. Akorn Recent Development Table 143. Key Raw Materials Table 144. Raw Materials Key Suppliers Table 145. Hydromorphone Distributors List Table 146. Hydromorphone Customers List Table 147. Research Programs/Design for This Report Table 148. Authors List of This Report Table 149. Secondary Sources Table 150. Primary Sources List of Figures Figure 1. Hydromorphone Product Image Figure 2. Global Hydromorphone Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Hydromorphone Sales Value (2021-2032) & (US$ Million) Figure 4. Global Hydromorphone Sales (2021-2032) & (K Units) Figure 5. Global Hydromorphone Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Hydromorphone Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Oral Image Figure 10. Injection Image Figure 11. Global Hydromorphone Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Hydromorphone Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Hydromorphone Sales Volume Share by Type (2021-2032) Figure 14. Global Hydromorphone Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Hydromorphone Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Hydromorphone Sales Value Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Drug Store Image Figure 19. Global Hydromorphone Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Hydromorphone Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Hydromorphone Sales Volume Share by Application (2021-2032) Figure 22. Global Hydromorphone Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Hydromorphone Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Hydromorphone Sales Value Share by Application (2021-2032) Figure 25. Global Hydromorphone Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 26. Global Hydromorphone Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Hydromorphone Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Hydromorphone Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Hydromorphone Sales Value (2021-2032) & (US$ Million) Figure 30. North America Hydromorphone Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Hydromorphone Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Hydromorphone Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Hydromorphone Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Hydromorphone Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Hydromorphone Sales Value (2021-2032) & (US$ Million) Figure 36. South America Hydromorphone Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Hydromorphone Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Hydromorphone Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Hydromorphone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Hydromorphone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Hydromorphone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Hydromorphone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Hydromorphone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Hydromorphone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Hydromorphone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Hydromorphone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Hydromorphone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Hydromorphone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Hydromorphone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Hydromorphone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Hydromorphone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Hydromorphone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Hydromorphone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Hydromorphone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Hydromorphone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Hydromorphone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Hydromorphone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Hydromorphone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Hydromorphone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Hydromorphone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Hydromorphone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Hydromorphone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Hydromorphone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Hydromorphone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Hydromorphone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Hydromorphone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Hydromorphone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Hydromorphone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Hydromorphone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Hydromorphone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Hydromorphone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Hydromorphone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Hydromorphone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Hydromorphone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Hydromorphone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Hydromorphone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Hydromorphone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Hydromorphone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Hydromorphone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Hydromorphone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Hydromorphone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Hydromorphone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Hydromorphone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Hydromorphone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Hydromorphone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Hydromorphone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Hydromorphone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Hydromorphone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Hydromorphone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Hydromorphone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Hydromorphone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Hydromorphone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Hydromorphone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Hydromorphone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Hydromorphone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Hydromorphone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Hydromorphone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Hydromorphone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Hydromorphone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Hydromorphone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Hydromorphone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Hydromorphone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Hydromorphone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Hydromorphone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Hydromorphone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Hydromorphone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Hydromorphone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Hydromorphone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Hydromorphone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Hydromorphone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Hydromorphone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Hydromorphone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Hydromorphone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Hydromorphone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Hydromorphone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Hydromorphone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Hydromorphone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Hydromorphone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Hydromorphone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Hydromorphone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Hydromorphone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Hydromorphone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Hydromorphone Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Hydromorphone Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • Oral
  • Injection
Applications
  • Hospital
  • Drug Store
Companies covered
  • Teva Pharmaceuticals
  • Johnson & Johnson
  • Novartis
  • Mylan
  • Pfizer
  • Fresenius
  • Watson Laboratories
  • Stada Arzneimittel
  • Purdue Pharma
  • Mundipharma
  • Mallinckrodt
  • Lannett
  • KV Pharmaceutical
  • Barr Pharmaceuticals
  • Apotex
  • Akorn

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Hydromorphone Sales Value (2021-2032)
  4. 1.2.2 Global Hydromorphone Sales Volume (2021-2032)
  5. 1.2.3 Global Hydromorphone Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Hydromorphone Market Dynamics
  1. 2.1 Hydromorphone Industry Trends
  2. 2.2 Hydromorphone Industry Drivers
  3. 2.3 Hydromorphone Industry Opportunities and Challenges
  4. 2.4 Hydromorphone Industry Restraints
3 Hydromorphone Market by Company
  1. 3.1 Global Hydromorphone Company Revenue Ranking in 2025
  2. 3.2 Global Hydromorphone Revenue by Company (2021-2026)
  3. 3.3 Global Hydromorphone Sales Volume by Company (2021-2026)
  4. 3.4 Global Hydromorphone Average Price by Company (2021-2026)
  5. 3.5 Global Hydromorphone Company Ranking (2024-2026)
  6. 3.6 Global Hydromorphone Company Manufacturing Base and Headquarters
  7. 3.7 Global Hydromorphone Company Product Type and Application
  8. 3.8 Global Hydromorphone Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Hydromorphone Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Hydromorphone Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Hydromorphone Market by Type
  1. 4.1 Hydromorphone Type Introduction
  2. 4.1.1 Oral
  3. 4.1.2 Injection
  4. 4.2 Global Hydromorphone Sales Volume by Type
  5. 4.2.1 Global Hydromorphone Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Hydromorphone Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Hydromorphone Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Hydromorphone Sales Value by Type
  9. 4.3.1 Global Hydromorphone Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Hydromorphone Sales Value by Type (2021-2032)
  11. 4.3.3 Global Hydromorphone Sales Value Share by Type (2021-2032)
5 Hydromorphone Market by Application
  1. 5.1 Hydromorphone Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Drug Store
  4. 5.2 Global Hydromorphone Sales Volume by Application
  5. 5.2.1 Global Hydromorphone Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Hydromorphone Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Hydromorphone Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Hydromorphone Sales Value by Application
  9. 5.3.1 Global Hydromorphone Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Hydromorphone Sales Value by Application (2021-2032)
  11. 5.3.3 Global Hydromorphone Sales Value Share by Application (2021-2032)
6 Hydromorphone Regional Sales and Value Analysis
  1. 6.1 Global Hydromorphone Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Hydromorphone Sales by Region (2021-2032)
  3. 6.2.1 Global Hydromorphone Sales by Region: 2021-2026
  4. 6.2.2 Global Hydromorphone Sales by Region (2027-2032)
  5. 6.3 Global Hydromorphone Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Hydromorphone Sales Value by Region (2021-2032)
  7. 6.4.1 Global Hydromorphone Sales Value by Region: 2021-2026
  8. 6.4.2 Global Hydromorphone Sales Value by Region (2027-2032)
  9. 6.5 Global Hydromorphone Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Hydromorphone Sales Value (2021-2032)
  12. 6.6.2 North America Hydromorphone Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Hydromorphone Sales Value (2021-2032)
  15. 6.7.2 Europe Hydromorphone Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Hydromorphone Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Hydromorphone Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Hydromorphone Sales Value (2021-2032)
  21. 6.9.2 South America Hydromorphone Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Hydromorphone Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Hydromorphone Sales Value Share by Country, 2025 VS 2032
7 Hydromorphone Country-level Sales and Value Analysis
  1. 7.1 Global Hydromorphone Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Hydromorphone Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Hydromorphone Sales by Country (2021-2032)
  4. 7.3.1 Global Hydromorphone Sales by Country (2021-2026)
  5. 7.3.2 Global Hydromorphone Sales by Country (2027-2032)
  6. 7.4 Global Hydromorphone Sales Value by Country (2021-2032)
  7. 7.4.1 Global Hydromorphone Sales Value by Country (2021-2026)
  8. 7.4.2 Global Hydromorphone Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Hydromorphone Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Hydromorphone Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Hydromorphone Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Hydromorphone Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Hydromorphone Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Hydromorphone Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Hydromorphone Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Hydromorphone Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Hydromorphone Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Hydromorphone Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Hydromorphone Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Hydromorphone Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Hydromorphone Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Hydromorphone Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Hydromorphone Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Hydromorphone Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Hydromorphone Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Hydromorphone Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Hydromorphone Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Hydromorphone Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Hydromorphone Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Hydromorphone Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Hydromorphone Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Hydromorphone Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Hydromorphone Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Hydromorphone Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Hydromorphone Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Hydromorphone Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Hydromorphone Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Hydromorphone Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Hydromorphone Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Hydromorphone Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Hydromorphone Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Hydromorphone Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Hydromorphone Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Hydromorphone Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Hydromorphone Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Hydromorphone Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Hydromorphone Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Hydromorphone Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Hydromorphone Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Hydromorphone Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Hydromorphone Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Hydromorphone Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Hydromorphone Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Hydromorphone Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Hydromorphone Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Hydromorphone Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Hydromorphone Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Hydromorphone Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Hydromorphone Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Hydromorphone Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Hydromorphone Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Hydromorphone Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Hydromorphone Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Hydromorphone Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Hydromorphone Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Hydromorphone Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Hydromorphone Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Hydromorphone Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Hydromorphone Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Hydromorphone Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Hydromorphone Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Hydromorphone Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Hydromorphone Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Hydromorphone Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Hydromorphone Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Hydromorphone Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Hydromorphone Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Hydromorphone Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Hydromorphone Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Hydromorphone Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Hydromorphone Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Hydromorphone Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Hydromorphone Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Hydromorphone Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Hydromorphone Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Hydromorphone Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Hydromorphone Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Hydromorphone Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Hydromorphone Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Hydromorphone Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Hydromorphone Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Hydromorphone Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva Pharmaceuticals
  2. 8.1.1 Teva Pharmaceuticals Company Information
  3. 8.1.2 Teva Pharmaceuticals Business Overview
  4. 8.1.3 Teva Pharmaceuticals Hydromorphone Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Teva Pharmaceuticals Hydromorphone Product Portfolio
  6. 8.1.5 Teva Pharmaceuticals Recent Developments
  7. 8.2 Johnson & Johnson
  8. 8.2.1 Johnson & Johnson Company Information
  9. 8.2.2 Johnson & Johnson Business Overview
  10. 8.2.3 Johnson & Johnson Hydromorphone Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Johnson & Johnson Hydromorphone Product Portfolio
  12. 8.2.5 Johnson & Johnson Recent Developments
  13. 8.3 Novartis
  14. 8.3.1 Novartis Company Information
  15. 8.3.2 Novartis Business Overview
  16. 8.3.3 Novartis Hydromorphone Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Novartis Hydromorphone Product Portfolio
  18. 8.3.5 Novartis Recent Developments
  19. 8.4 Mylan
  20. 8.4.1 Mylan Company Information
  21. 8.4.2 Mylan Business Overview
  22. 8.4.3 Mylan Hydromorphone Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Mylan Hydromorphone Product Portfolio
  24. 8.4.5 Mylan Recent Developments
  25. 8.5 Pfizer
  26. 8.5.1 Pfizer Company Information
  27. 8.5.2 Pfizer Business Overview
  28. 8.5.3 Pfizer Hydromorphone Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Pfizer Hydromorphone Product Portfolio
  30. 8.5.5 Pfizer Recent Developments
  31. 8.6 Fresenius
  32. 8.6.1 Fresenius Company Information
  33. 8.6.2 Fresenius Business Overview
  34. 8.6.3 Fresenius Hydromorphone Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Fresenius Hydromorphone Product Portfolio
  36. 8.6.5 Fresenius Recent Developments
  37. 8.7 Watson Laboratories
  38. 8.7.1 Watson Laboratories Company Information
  39. 8.7.2 Watson Laboratories Business Overview
  40. 8.7.3 Watson Laboratories Hydromorphone Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Watson Laboratories Hydromorphone Product Portfolio
  42. 8.7.5 Watson Laboratories Recent Developments
  43. 8.8 Stada Arzneimittel
  44. 8.8.1 Stada Arzneimittel Company Information
  45. 8.8.2 Stada Arzneimittel Business Overview
  46. 8.8.3 Stada Arzneimittel Hydromorphone Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Stada Arzneimittel Hydromorphone Product Portfolio
  48. 8.8.5 Stada Arzneimittel Recent Developments
  49. 8.9 Purdue Pharma
  50. 8.9.1 Purdue Pharma Company Information
  51. 8.9.2 Purdue Pharma Business Overview
  52. 8.9.3 Purdue Pharma Hydromorphone Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Purdue Pharma Hydromorphone Product Portfolio
  54. 8.9.5 Purdue Pharma Recent Developments
  55. 8.10 Mundipharma
  56. 8.10.1 Mundipharma Company Information
  57. 8.10.2 Mundipharma Business Overview
  58. 8.10.3 Mundipharma Hydromorphone Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Mundipharma Hydromorphone Product Portfolio
  60. 8.10.5 Mundipharma Recent Developments
  61. 8.11 Mallinckrodt
  62. 8.11.1 Mallinckrodt Company Information
  63. 8.11.2 Mallinckrodt Business Overview
  64. 8.11.3 Mallinckrodt Hydromorphone Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Mallinckrodt Hydromorphone Product Portfolio
  66. 8.11.5 Mallinckrodt Recent Developments
  67. 8.12 Lannett
  68. 8.12.1 Lannett Company Information
  69. 8.12.2 Lannett Business Overview
  70. 8.12.3 Lannett Hydromorphone Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Lannett Hydromorphone Product Portfolio
  72. 8.12.5 Lannett Recent Developments
  73. 8.13 KV Pharmaceutical
  74. 8.13.1 KV Pharmaceutical Company Information
  75. 8.13.2 KV Pharmaceutical Business Overview
  76. 8.13.3 KV Pharmaceutical Hydromorphone Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 KV Pharmaceutical Hydromorphone Product Portfolio
  78. 8.13.5 KV Pharmaceutical Recent Developments
  79. 8.14 Barr Pharmaceuticals
  80. 8.14.1 Barr Pharmaceuticals Company Information
  81. 8.14.2 Barr Pharmaceuticals Business Overview
  82. 8.14.3 Barr Pharmaceuticals Hydromorphone Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Barr Pharmaceuticals Hydromorphone Product Portfolio
  84. 8.14.5 Barr Pharmaceuticals Recent Developments
  85. 8.15 Apotex
  86. 8.15.1 Apotex Company Information
  87. 8.15.2 Apotex Business Overview
  88. 8.15.3 Apotex Hydromorphone Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Apotex Hydromorphone Product Portfolio
  90. 8.15.5 Apotex Recent Developments
  91. 8.16 Akorn
  92. 8.16.1 Akorn Company Information
  93. 8.16.2 Akorn Business Overview
  94. 8.16.3 Akorn Hydromorphone Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Akorn Hydromorphone Product Portfolio
  96. 8.16.5 Akorn Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Hydromorphone Value Chain Analysis
  2. 9.1.1 Hydromorphone Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Hydromorphone Sales Mode & Process
  6. 9.2 Hydromorphone Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Hydromorphone Distributors
  9. 9.2.3 Hydromorphone Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst